MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17512433.2016.1208563

Медицинская библиотека · Expert review of clinical pharmacology · 2016

Silibinin: a potential old drug for cancer therapy.

Zhu Xing-Xing, Ding Ya-Hui, Wu Yi, Qian Lin-Yan, Zou Hai, He Qiang

СтатьяПеревод пока не подготовлен

Аннотация

Silibinin is mixture of flavonolignans extracted from milk thistle and often has been used in the treatment of acute and chronic liver disorders caused by toxins, drug, alcohol and hepatitis and gall bladder disorders for its antioxidant and hepatoprotective properties. Areas covered: However, increasing evidence suggest that silibinin is not solely limited in the treatment of these diseases. Further research suggests that silymarin may function diversely and may serve as a novel therapy for cancer therapy, such as lung cancer, prostatic cancer, colon cancer, breast cancer, bladder cancer and hepatocellular carcinoma by regulating cancer cells growth, proliferation, apoptosis, angiogenesis and many other mechanism. Expert commentary: In this review, in order to provide potential new treatment for these cancer, we summarize the recent anti-cancer findings of silibinin in these cancer and clarify the mechanisms of this effect.

Для цитирования: Zhu Xing-Xing, Ding Ya-Hui, Wu Yi, Qian Lin-Yan, Zou Hai, He Qiang. Silibinin: a potential old drug for cancer therapy.. Expert review of clinical pharmacology. 2016. DOI: 10.1080/17512433.2016.1208563.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.